Expression of Tumor-Associated Macrophage in Progression of Human Glioma

Cell Biochemistry and Biophysics

Volumn 70, Issue 3, 2014, Pages 1625-1631

  Ding, Peng ^a   Wang, Weimin ^a   Wang, Jinkun ^a   Yang, Zhiyong ^a   Xue, Liping ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Yunnan NO2 Provincial People's Hospital   (China)

Author keywords

Glioma; Immunohistochemistry; Prognosis; Tumor associated macrophages

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ADULT; AGED; BRAIN TUMOR; FEMALE; GLIOMA; HUMAN; IMMUNOLOGY; MACROPHAGE; MALE; MIDDLE AGED; PATHOLOGY; TUMOR INVASION;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; FEMALE; GLIOMA; GPI-LINKED PROTEINS; HUMANS; LECTINS, C-TYPE; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, CELL SURFACE; RECEPTORS, IGG;

EID: 84919948277     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0105-3     Document Type: Article

References (24)

1. Huse, J. T., & Holland, E. C. (2010). Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nature Reviews Cancer,10(5), 319–331.
2. Louis, D. N., et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica,114(2), 97–109.
3. Liu, S., et al. (2012). CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Research,14(2), R48.
4. Deschoolmeester, V., et al. (2010). Tumor infiltrating lymphocytes: An intriguing player in the survival of colorectal cancer patients. BMC Immunology,11, 19.
5. Cui, X., et al. (2013). Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for glioblastoma. International Research Journal of Biological Sciences,9(2), 134–141.
6. Casulo, C., et al. (2013). Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma. Leukemia Research,37(9), 1178–1183.
7. da Fonseca, A. C., & Badie, B. (2013). Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clinical and Developmental Immunology,2013, 264124.
8. Kennedy, B. C., et al. (2013). Tumor-associated macrophages in glioma: friend or foe? Journal of Oncology,2013, 486912.
9. Fleming, A. J., & Chi, S. N. (2012). Brain tumors in children. Current Problems in Pediatrics and Adolescent Health Care,42(4), 80–103.
10. Hartmann, C., et al. (2013). Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical Cancer Research,19(18), 5146–5157.
11. Bogler, O., et al. (1995). The p53 gene and its role in human brain tumors. Glia,15(3), 308–327.
12. Stupp, R., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine,352(10), 987–996.
13. Guo, C., et al. (2013). The role of tumor-associated macrophages in tumor vascularization. Vascular Cell,5(1), 20.
14. Charles, N. A., et al. (2012). The brain tumor microenvironment. Glia,60(3), 502–514.
15. Miescher, S., et al. (1988). In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. Journal of Neurosurgery,68(3), 438–448.
16. Zhang, B., et al. (2011). M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics (Sao Paulo),66(11), 1879–1886.
17. Ding, T., et al. (2009). High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Human Pathology,40(3), 381–389.
18. Quatromoni, J. G., & Eruslanov, E. (2012). Tumor-associated macrophages: Function, phenotype, and link to prognosis in human lung cancer. American Journal of Translational Research,4(4), 376–389.
19. Lievense, L. A., et al. (2013). Tumor-associated macrophages in thoracic malignancies. Lung Cancer,80(3), 256–262.
20. Sica, A., & Mantovani, A. (2012). Macrophage plasticity and polarization: In vivo veritas. Journal of Clinical Investigation,122(3), 787–795.
21. Siveen, K. S., & Kuttan, G. (2009). Role of macrophages in tumour progression. Immunology Letters,123(2), 97–102.
22. Bingle, L., Brown, N. J., & Lewis, C. E. (2002). The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. Journal of Pathology,196(3), 254–265.
23. Baay, M., et al. (2011). Tumor cells and tumor-associated macrophages: Secreted proteins as potential targets for therapy. Clinical and Developmental Immunology,2011, 565187.
24. Buford, T. W., & Anton, S. D. (2014). Resveratrol as a supplement to exercise training: friend or foe? Journal of Physiology,592(Pt 3), 551–552.